Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q2 2023 · 10-Q
Revenue$18.08M$18.08M−3.2% vs Q2 2022 Net Income-$3.31M-$3.31MN/M vs Q2 2022 EPS Diluted-$0.18-$0.18N/M vs Q2 2022 Gross Profit$1,033,000−40.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,740,000N/M Margins · derivedGross margin5.7%−3.6 pt vs Q2 2022
Operating margin-16.4%+7.6 pt vs Q2 2022
Net margin-18.3%+8.3 pt vs Q2 2022
ended Jun 30, 2023 · filed Aug 14, 2023 · 45 d after period end